Middle-ear infections are a common affliction in early life, affecting more than 80% of children in the U.S. Antibiotics are often employed as a first line of defense but sometimes fail against the pathogenic bacteria that can develop in the middle ear, just behind the eardrum. In a new study, researchers explore the use of microplasma -- a highly focused stream of chemically excited ions and molecules -- as a noninvasive method for attacking the bacterial biofilms that resist antibiotic treatment in the middle ear.
source https://www.sciencedaily.com/releases/2021/07/210729122031.htm
Friday, 30 July 2021
Related Posts
Experiments confirm a quantum material’s unique response to circularly polarized laser lightScientists are probing topological insulators with circularly polarize… Read More
Resistance is not futile: Predicting how changes in production, materials impact EV battery lifeAs demand for electric vehicle batteries continues to grow, researcher… Read More
New study suggests that breastfeeding may help prevent cognitive declineA new study has found that women over the age of 50 who had breastfed … Read More
Slow release of a drug, TT-10, improves heart attack recovery in a mouse modelA pharmaceutical product called TT-10, which spurs proliferation of he… Read More
A big leap forward in using iron catalysts for pharmaceuticalsResearchers have created and characterized a novel, three-component cr… Read More
Machine learning predicts antibiotic resistance spreadGenes aren't only inherited through birth. Bacteria have the ability t… Read More
0 comments: